文献速递心脑血管急症

长期暴露于环境细颗粒物与卒中发病:中国-PAR项目前瞻性队列研究

Long term exposure to ambient fine particulate matter and incidence of stroke: prospective cohort study from the China-PAR project.
PubMed 文献 · BMJ · 2019-12-30
一句话结论中国成人长期暴露于较高浓度PM2.5与总卒中、缺血性卒中及出血性卒中发病风险正相关,且呈近乎线性的暴露-反应关系。

该研究基于中国-PAR项目前瞻性队列,纳入中国15个省份117 575名基线无卒中的成人,评估长期(2000-2015年)居住地PM2.5暴露与卒中发病的关系。随访900 214人年期间识别3540例新发卒中,其中缺血性卒中占63.0%(n=2230)、出血性卒中占27.5%(n=973)。与PM2.5暴露第一四分位(<54.5 μg/m3)相比,最高四分位(>78.2 μg/m3)者总卒中风险升高(HR 1.53,95%CI 1.34-1.74),缺血性卒中(HR 1.82,95%CI 1.55-2.14)和出血性卒中(HR 1.50,95%CI 1.16-1.93)风险亦升高。PM2.5浓度每增加10 μg/m3,总卒中、缺血性卒中和出血性卒中风险分别增加13%(HR 1.13,95%CI 1.09-1.17)、20%(HR 1.20,95%CI 1.15-1.25)和12%(HR 1.12,95%CI 1.05-1.20)。

要点

  • 长期平均PM2.5暴露最高四分位(>78.2 μg/m3)者较第一四分位(<54.5 μg/m3)总卒中风险升高(HR 1.53,95%CI 1.34-1.74)。
  • PM2.5浓度每增加10 μg/m3,缺血性卒中风险增加20%(HR 1.20,95%CI 1.15-1.25),出血性卒中风险增加12%(HR 1.12,95%CI 1.05-1.20)。
  • 长期PM2.5暴露与总卒中及其亚型的暴露-反应关系近乎线性。
  • 研究人群为中国15个省份117 575名基线无卒中的成人,随访900 214人年识别3540例新发卒中。

适用人群与场景

  • 中国15个省份117 575名基线无卒中的中国男性和女性成人。

研究设计与关键结果

  • 研究设计:基于人群的前瞻性队列研究,数据来自中国-PAR项目,覆盖中国15个省份。
  • 暴露评估:2000至2015年参与者居住地长期平均PM2.5水平为64.9 μg/m3,范围31.2 μg/m3至97.0 μg/m3。
  • 随访与结局:随访900 214人年,识别3540例新发卒中,其中缺血性卒中占63.0%(n=2230)、出血性卒中占27.5%(n=973)。
  • 主要结果:与PM2.5暴露第一四分位(<54.5 μg/m3)相比,最高四分位(>78.2 μg/m3)者总卒中风险升高(HR 1.53,95%CI 1.34-1.74),缺血性卒中(HR 1.82,95%CI 1.55-2.14)和出血性卒中(HR 1.50,95%CI 1.16-1.93)风险亦升高。
  • 剂量-反应:PM2.5浓度每增加10 μg/m3,总卒中风险增加13%(HR 1.13,95%CI 1.09-1.17),缺血性卒中增加20%(HR 1.20,95%CI 1.15-1.25),出血性卒中增加12%(HR 1.12,95%CI 1.05-1.20)。
  • 暴露-反应关系:长期PM2.5暴露与总卒中及其亚型发病率呈近乎线性的暴露-反应关系。

证据类型、等级与局限

  • 证据类型:基于人群的前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该研究为中国长期暴露于较高浓度环境PM2.5与卒中及其主要亚型发病正相关提供了证据。
  • 作者认为,这些发现对空气污染与卒中预防相关的环境和卫生政策制定有意义,不仅在中国,也适用于其他低收入和中等收入国家。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To study the effect of long term exposure to ambient fine particulate matter of diameter ≤2.5 μm (PM2.5) on the incidence of total, ischemic, and hemorrhagic stroke among Chinese adults.

DESIGN: Population based prospective cohort study.

SETTING: Prediction for Atherosclerotic Cardiovascular Disease Risk in China (China-PAR) project carried out in 15 provinces across China.

PARTICIPANTS: 117 575 Chinese men and women without stroke at baseline in the China-PAR project.

MAIN OUTCOME MEASURES: Incidence of total, ischemic, and hemorrhagic stroke.

RESULTS: The long term average PM2.5 level from 2000 to 2015 at participants' residential addresses was 64.9 μg/m3, ranging from 31.2 μg/m3 to 97.0 μg/m3. During 900 214 person years of follow-up, 3540 cases of incident stroke were identified, of which 63.0% (n=2230) were ischemic and 27.5% (n=973) were hemorrhagic. Compared with the first quarter of exposure to PM2.5 (<54.5 μg/m3), participants in the highest quarter (>78.2 μg/m3) had an increased risk of incident stroke (hazard ratio 1.53, 95% confidence interval 1.34 to 1.74), ischemic stroke (1.82, 1.55 to 2.14), and hemorrhagic stroke (1.50, 1.16 to 1.93). For each increase of 10 μg/m3 in PM2.5 concentration, the increased risks of incident stroke, ischemic stroke, and hemorrhagic stroke were 13% (1.13, 1.09 to 1.17), 20% (1.20, 1.15 to 1.25), and 12% (1.12, 1.05 to 1.20), respectively. Almost linear exposure-response relations between long term exposure to PM2.5 and incident stroke, overall and by its subtypes, were observed.

CONCLUSIONS: This study provides evidence from China that long term exposure to ambient PM2.5 at relatively high concentrations is positively associated with incident stroke and its major subtypes. These findings are meaningful for both environmental and health policy development related to air pollution and stroke prevention, not only in China, but also in other low and middle income countries.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Huang K, Liang F, Yang X, et al. Long term exposure to ambient fine particulate matter and incidence of stroke: prospective cohort study from the China-PAR project. BMJ. 2019. PMID: 31888885. doi:10.1136/bmj.l6720

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。